You are here

Genta

Biotech Stock Mailbag: Bio-Hazards

The Street

Sat, 03/26/11 - 10:00 am

Cell Therapeutics

Pooled Results of Early Endpoints from Phase 3 Trials of Genasense® in Advanced Melanoma Presented at ASCO

Yahoo/BusinessWire

Sun, 06/6/10 - 10:51 am

Allon, Genta programs win FDA fast-track status

Fierce Biotech

Wed, 04/7/10 - 10:19 am

Allon Therapeutics

Genta starts phase-2 trial of oncology product Tesetaxal

Pharmabiz

Sat, 02/27/10 - 01:17 pm

tubulin inhibitor

Has Genta's Energizer Bunny of Cancer Drugs Finally Run Out of Juice?

BNET Pharma

Thu, 11/5/09 - 08:50 am

Genta Melanoma Drug Study Disappoints

TheStreet.com

Thu, 10/29/09 - 09:03 am

Genta Announces Closing of $10 Million in Two Offerings of Common Stock and Convertible Notes

Yahoo/BusinessWire

Sun, 09/6/09 - 01:01 pm

Hot Biotech Events for Next Week: BioBuzz

TheStreet.com

Fri, 09/4/09 - 08:49 am

Cell Therapeutics

Osiris Therapeutics